Market Overview

Jazz Pharma Issues Warning Against Using Xyrem with Alcohol, Drugs Which Cause Respiratory Depression

Share:
Related JAZZ
Goldman Initiates Specialty Pharma At Neutral, Highlights 'A Confluence Of Concerns'
Goldman Sees 26% Upside In Jazz Pharma Shares
Investing With Zedge - A Cheap Spin-Off With Upside (Seeking Alpha)

View FDA page.

Posted-In: News FDA

 

Related Articles (JAZZ)

View Comments and Join the Discussion!